Newsletter
American Society of Gene & Cell Therapy's 20th Annual Meeting: Washington, DC., May 10-13, 2017 | ASC
ASGCT 2017 Annual Meeting: Washington DC, May 10-13, 2017
Applied StemCell's CRISPR/Cas9 technology specialists will be attending the 20th Annual Meeting of the American Society of Gene & Cancer Therapy and will also be at booth #205. We welcome all attendees to come and visit with us, to learn about Applied StemCell's gene therapy pipeline offerings to help researchers. We also offer comprehensive service to generate the most advanced preclinical animal and cell line models for research and drug development.
This meeting is a global forum for discussions, information sharing and networking for researchers seeking the latest strategies & developments in gene & cell therapy, regulatory affairs and clinical trials.
ASC's scientific advisory board member, Dr. Xianmin Zeng will also be giving a talk on "Making multiple therapeutic cell products from a cGMP-compliant iPSC line" in the Tools and Technologies Forum
PRESENTAION DETAILS:
Date: Fri May 12, 2017
Time: 7:00-7:15 pm
Speaker: Xianmin Zeng, Ph.D., Scientific Advisory Board, Applied StemCell, Inc. Milpitas, CA USA
Forum: Tools & Technologies
CONFERENCE DETAILS:
Dates: May 10-13, 2017
Venue: Marriott Wardman Park Hotel, Washington, DC, USA.
Website: http://www.asgct.org/meetings-educational-programs/asgct-annual-meetings/2017-annual-meeting